Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

February 21, 2024

IsomAb secures funds to advance peripheral arterial disease treatment

UK-based biotechnology company IsomAb has secured £7.5m (approximately $9.4m) in a seed funding round to expedite the development of its lead candidate targeting peripheral arterial disease.

IsomAb secures funds to advance peripheral arterial disease treatment